Trevi therapeutics, inc. (TRVI)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18
Assets
Current assets:
Cash and cash equivalents

52,640

57,313

63,515

71,387

12,946

7,202

Tax credit and other receivables

125

558

203

251

150

184

Prepaid expenses

1,055

1,681

1,826

2,970

1,668

1,438

Total current assets

53,820

59,552

65,544

74,608

14,764

8,824

Deferred offering costs

-

-

-

-

-

1,534

Deferred offering costs

-

-

-

-

1,885

-

Operating lease right-of-use asset

292

312

331

350

368

-

Security deposit

19

19

19

19

19

19

Property, equipment and leasehold improvements, net

107

118

128

139

149

149

Total assets

54,238

60,001

66,022

75,116

17,185

10,526

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable

2,193

1,599

489

2,663

498

603

Accrued expenses

4,911

3,501

4,446

4,351

3,079

2,073

Operating lease liability - current portion

102

99

95

91

88

-

Total current liabilities

7,206

5,199

5,030

7,105

3,665

2,676

Obligation for loan success fee

-

-

-

-

512

460

Series C redeemable convertible preferred stock liability

-

-

-

-

-

1,096

Operating lease liability - long term portion

230

257

283

308

333

46

Stockholders’ equity (deficit):
Common stock: $0.001 par value; 200,000,000 shares authorized at March 31, 2020 and December 31, 2019, respectively; and 17,834,570 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively.

18

18

18

18

4

4

Additional paid-in capital

169,476

168,746

168,373

168,002

-

-

Accumulated deficit

-122,692

-114,219

-107,682

-100,317

-115,480

-109,498

Total stockholders’ equity

46,802

54,545

60,709

67,703

-115,476

-109,494

Total liabilities and stockholders’ equity

54,238

60,001

66,022

75,116

17,185

10,526

Series A Redeemable convertible Preferred Stock [Member]
Temporary Equity, Carrying Amount, Attributable to Parent

-

-

-

-

21,169

21,033

Total stockholders’ equity (deficit)

-

-

-

-

21,169

21,033

Series B Redeemable convertible Preferred Stock [Member]
Temporary Equity, Carrying Amount, Attributable to Parent

-

-

-

-

33,943

33,686

Total stockholders’ equity (deficit)

-

-

-

-

33,943

33,686

Series C Redeemable convertible Preferred Stock [Member]
Temporary Equity, Carrying Amount, Attributable to Parent

-

-

-

-

73,039

61,023

Total stockholders’ equity (deficit)

-

-

-

-

73,039

61,023